cGxP.wire https://validator.w3.org/feed/docs/rss2.html NIPRO Wins FDA Clearance for ELISIO-HX Expanded HD Dialyzer Ractigen Therapeutics Closes $31M Financing to Advance saRNA Pipeline Hippocratic AI Launches Rapid Response Climate Agents for Healthcare Karyopharm Eyes Accelerated FDA Approval for Selinexor Cytokinetics Wins UK Approval for MYQORZO in oHCM Amgen’s Repatha Wins CHMP Support for Broader Heart Protection Kaigene, Taisho Advance KG006 Autoimmune Therapy Deal Italfarmaco Secures Managed Entry Agreement for Duvyzat in Georgia 10x Genomics, CHUV Advance Precision Cancer Diagnostics Tiziana Life Sciences Reports Positive Foralumab Data in Third MSA Patient CREATE, Monash Partner to Advance In Vivo CAR-T Platform Ratio Therapeutics Raises $70 Million to Advance Radiotherapeutics Curis Advances TakeAim CLL Trial with First Patients Dosed Contineum Therapeutics Affirms Phase 2 Milestones and Cash Runway Amplia Therapeutics Reports Promising Preclinical Narmafotinib Data in Pancreatic Cancer EVERSANA, Innovacell Partner to Advance ICEF15 Cell Therapy Moleculin Reports Positive Interim MIRACLE Trial Data in Venetoclax-Failed AML Patients Daiichi Sankyo and AstraZeneca Receive EU Approval for Datroway in First-Line Metastatic TNBC CREATE Launches First Human Trial of In Vivo CAR-T Therapy Fresenius Kabi’s Vedolizumab Biosimilar Accepted for FDA and EMA Review Polpharma Biologics Secures FDA and EMA Review for PB016 Basking Reports BB-031 Stroke Therapy Preclinical Breakthrough Novo Nordisk Reports ZEUS Phase 3 Results for Ziltivekimab Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Study Abivax Aligns with FDA on Obefazimod NDA Submission Dario Expands Obesity Care with AI-Powered GLP-1 Program Apertura Reports Progress in AAV Gene Therapy for TSC1 Relation and GSK Expand $110M AI Drug Discovery Alliance Evommune Launches Phase 2b Trial of EVO756 for Migraine Prevention 60 Degrees Pharmaceuticals Reaches Babesiosis Study Enrollment Milestone Hyperfine Expands Clinical Evidence for Swoop Portable MRI MMI Advances REMIND Alzheimer’s Study After FDA IDE Approval Savara Secures European, Australian Patents for MOLBREEVI Through 2041 Lupin Boosts U.S. Generics Business with FDA Approval Caldera, Synlogic Unite in $278M Biotech Merger Sumitomo Pharma’s Enzomenib Gains FDA Orphan Drug Status for ALL Latigo Biotherapeutics Reports NEJM-Published Positive LTG-001 Acute Pain Trial Results AB2 Bio Lands $30M U.S. Deal for Tadekinig Alfa Pfizer Reports Positive Phase 3 Results for LITFULO in Vitiligo Smith+Nephew Sets New Standard in Sports Medicine AI Verdiva Bio Starts Phase 1 Trial of Weekly Oral VRB-103 Biocon Secures Health Canada Approval for Yesintek Pen IceCure Seeks NCCN Support for Breast Cancer Cryoablation Mesoblast Strengthens Cell Therapy Portfolio with RYONCIL Growth and FDA Progress Corbus Moves CRB-701 Toward FDA Registration Allogene Therapeutics Receives FDA RMAT Status for Cema-Cel Pfizer’s PREVNAR 20 Selected for Québec Pediatric Program ImmunityBio Receives UAE Marketing Authorization for ANKTIVA VB Spine Receives FDA Clearance for Expanded Vitoss Indications CalciMedica Aligns With FDA on Auxora Phase 2b Trial